Optimization of Ag-TiO2 nanocomposite at a low toxicity dose as a self-virucidal disinfectant against COVID-19
Self-virucidal Ag-TiO 2 nanocomposites at low toxicity dose could be a viable solution to reduce the risks posed by SARS-CoV-2 infection and excessive usage of disinfectants. We synthesized an Ag-TiO 2 nanocomposite suspension in a simple, low energy consumption, eco-friendly, one-pot process. PVP a...
Gespeichert in:
Veröffentlicht in: | Emergent materials (Online) 2023-08, Vol.6 (4), p.1259-1272 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Self-virucidal Ag-TiO
2
nanocomposites at low toxicity dose could be a viable solution to reduce the risks posed by SARS-CoV-2 infection and excessive usage of disinfectants. We synthesized an Ag-TiO
2
nanocomposite suspension in a simple, low energy consumption, eco-friendly, one-pot process. PVP and SDS were used in a 3:1 ratio as co-stabilizers, resulting in a uniform size with high stability. The nanocomposite characterization used UV–Vis spectroscopy, high-resolution transmission-electron-microscopy equipped with an energy dispersive X-ray spectroscope (HR-TEM, EDX), X-ray diffraction (XRD), and X-ray photoelectron spectroscopy (XPS). We determined the virucidal efficacy against SARS-CoV-2 by following ASTM E1052-20. The cytotoxicity test followed ISO 10993–5:2009. At high doses (50 ppm), the Ag-TiO
2
nanocomposite suspension showed ≥ 99.96% virucidal efficacy within 1 min, damaging the viral genome. At a low dosage (0.8 ppm), the viral infectivity was reduced by 99.86% within 24 h and minimized cytotoxicity. The viral protein had denatured, while the viral genome remained intact. The results suggest that the Ag-TiO
2
nanocomposite can be used in a more eco-friendly and safer manner as a potent broad spectrum virucidal disinfectant, offering broad action against unspecified targets (all virus proteins, not just the spike proteins), which could be helpful in all SARS-CoV-2 variants of concern. |
---|---|
ISSN: | 2522-5731 2522-574X |
DOI: | 10.1007/s42247-023-00520-0 |